Abstract
Numerous photosynthetic organisms possess bioactive properties, with algae standing out for their distinctive characteristics that attract interest from diverse industries. For instance, the pharmaceutical industry has great interest in features like the neuroprotective, anti-glycemic and cytotoxic properties found in some algae species. Nonetheless, it is imperative to design efficient systems capable of releasing the bioactive compounds present in these extracts. In this regard, nanoparticles have attracted considerable attention across various fields, particularly in drug delivery applications. Lipid-based nanoparticles have emerged as a promising solution, offering numerous advantages. These nanoparticles exhibit high biocompatibility and biodegradability, making them suitable for use in biological systems. Additionally, they possess the ability to encapsulate both hydrophilic and hydrophobic drugs, thereby expanding their versatility. One remarkable attribute of lipid-based nanoparticles is their ability to cross the blood–brain barrier, a crucial physical barrier responsible for regulating the entry of chemicals into the brain and maintaining central nervous system homeostasis. Overcoming this barrier presents a significant challenge in the treatment of central nervous system disorders. Therefore, the objective of this study is to provide an overview of the latest advancements in the nanoencapsulation of natural extracts using lipid-based vesicular delivery systems.